Distribution resumes of first and only medicine to treat plasminogen deficiency type 1 FORT LEE, N.J., April 29, 2024 /PRNewswire/ — Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.